Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Current Leases (2020 - 2025)

Palisade Bio has reported Current Leases over the past 6 years, most recently at $24000.0 for Q2 2025.

  • Quarterly Current Leases fell 81.54% to $24000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $24000.0 through Jun 2025, down 81.54% year-over-year, with the annual reading at $90000.0 for FY2024, 25.62% down from the prior year.
  • Current Leases was $24000.0 for Q2 2025 at Palisade Bio, down from $58000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $184000.0 in Q2 2021 and troughed at $24000.0 in Q2 2025.
  • The 5-year median for Current Leases is $112000.0 (2021), against an average of $107764.7.
  • Year-over-year, Current Leases surged 67.69% in 2023 and then tumbled 81.54% in 2025.
  • A 5-year view of Current Leases shows it stood at $112000.0 in 2021, then fell by 6.25% to $105000.0 in 2022, then grew by 15.24% to $121000.0 in 2023, then decreased by 25.62% to $90000.0 in 2024, then crashed by 73.33% to $24000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Current Leases are $24000.0 (Q2 2025), $58000.0 (Q1 2025), and $90000.0 (Q4 2024).